Report Detail

Request for Sample of this report

Service & Software Global AI In Clinical Trials Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4560266
    • |
  • 15 October, 2023
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global AI In Clinical Trials market size was valued at USD 48 million in 2022 and is forecast to a readjusted size of USD 74 million by 2029 with a CAGR of 6.5% during review period.
The AI in Clinical Trials market is experiencing significant growth and is expected to continue to expand in the coming years. AI, or artificial intelligence, is being increasingly utilized in the field of clinical trials to enhance various aspects of the trial process, including patient recruitment, data analysis, and drug development.One major trend in the AI in Clinical Trials market is the use of machine learning algorithms to improve patient recruitment and retention. AI algorithms can analyze large amounts of patient data and identify potential candidates for clinical trials more efficiently and accurately than traditional methods. This can help accelerate the recruitment process and ensure that trials have a diverse and representative patient population.
The Global Info Research report includes an overview of the development of the AI In Clinical Trials industry chain, the market status of Pharmaceutical and Biotechnology Companies (Software, Service), Contract Research Organization (Software, Service), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of AI In Clinical Trials.
Regionally, the report analyzes the AI In Clinical Trials markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global AI In Clinical Trials market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the AI In Clinical Trials market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the AI In Clinical Trials industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Software, Service).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the AI In Clinical Trials market.
Regional Analysis: The report involves examining the AI In Clinical Trials market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the AI In Clinical Trials market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to AI In Clinical Trials:
Company Analysis: Report covers individual AI In Clinical Trials players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards AI In Clinical Trials This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical and Biotechnology Companies, Contract Research Organization).
Technology Analysis: Report covers specific technologies relevant to AI In Clinical Trials. It assesses the current state, advancements, and potential future developments in AI In Clinical Trials areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the AI In Clinical Trials market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
AI In Clinical Trials market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Software
Service
Market segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organization
Other
Market segment by players, this report covers
Intel
The International Business Machines Corporation(IBM)
Koninklijke Philips N.V.
ConcertAl
Saama Technologies LLC
Samaa Technologies
Owkin Inc.
Numerate
Neuroute
AiCure
Ardigen
Unlearn Al
PathAl
Exscentia
Aitia Infotech Pvt Ltd.
Euretos
VeriSIM Life
Envisagenics
NURITAs
BioSymetrics
BioAge Labs lInc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI In Clinical Trials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI In Clinical Trials, with revenue, gross margin and global market share of AI In Clinical Trials from 2018 to 2023.
Chapter 3, the AI In Clinical Trials competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI In Clinical Trials market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI In Clinical Trials.
Chapter 13, to describe AI In Clinical Trials research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of AI In Clinical Trials
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI In Clinical Trials by Type
    • 1.3.1 Overview: Global AI In Clinical Trials Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global AI In Clinical Trials Consumption Value Market Share by Type in 2022
    • 1.3.3 Software
    • 1.3.4 Service
  • 1.4 Global AI In Clinical Trials Market by Application
    • 1.4.1 Overview: Global AI In Clinical Trials Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical and Biotechnology Companies
    • 1.4.3 Contract Research Organization
    • 1.4.4 Other
  • 1.5 Global AI In Clinical Trials Market Size & Forecast
  • 1.6 Global AI In Clinical Trials Market Size and Forecast by Region
    • 1.6.1 Global AI In Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global AI In Clinical Trials Market Size by Region, (2018-2029)
    • 1.6.3 North America AI In Clinical Trials Market Size and Prospect (2018-2029)
    • 1.6.4 Europe AI In Clinical Trials Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific AI In Clinical Trials Market Size and Prospect (2018-2029)
    • 1.6.6 South America AI In Clinical Trials Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa AI In Clinical Trials Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Intel
    • 2.1.1 Intel Details
    • 2.1.2 Intel Major Business
    • 2.1.3 Intel AI In Clinical Trials Product and Solutions
    • 2.1.4 Intel AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Intel Recent Developments and Future Plans
  • 2.2 The International Business Machines Corporation(IBM)
    • 2.2.1 The International Business Machines Corporation(IBM) Details
    • 2.2.2 The International Business Machines Corporation(IBM) Major Business
    • 2.2.3 The International Business Machines Corporation(IBM) AI In Clinical Trials Product and Solutions
    • 2.2.4 The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 The International Business Machines Corporation(IBM) Recent Developments and Future Plans
  • 2.3 Koninklijke Philips N.V.
    • 2.3.1 Koninklijke Philips N.V. Details
    • 2.3.2 Koninklijke Philips N.V. Major Business
    • 2.3.3 Koninklijke Philips N.V. AI In Clinical Trials Product and Solutions
    • 2.3.4 Koninklijke Philips N.V. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Koninklijke Philips N.V. Recent Developments and Future Plans
  • 2.4 ConcertAl
    • 2.4.1 ConcertAl Details
    • 2.4.2 ConcertAl Major Business
    • 2.4.3 ConcertAl AI In Clinical Trials Product and Solutions
    • 2.4.4 ConcertAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 ConcertAl Recent Developments and Future Plans
  • 2.5 Saama Technologies LLC
    • 2.5.1 Saama Technologies LLC Details
    • 2.5.2 Saama Technologies LLC Major Business
    • 2.5.3 Saama Technologies LLC AI In Clinical Trials Product and Solutions
    • 2.5.4 Saama Technologies LLC AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Saama Technologies LLC Recent Developments and Future Plans
  • 2.6 Samaa Technologies
    • 2.6.1 Samaa Technologies Details
    • 2.6.2 Samaa Technologies Major Business
    • 2.6.3 Samaa Technologies AI In Clinical Trials Product and Solutions
    • 2.6.4 Samaa Technologies AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Samaa Technologies Recent Developments and Future Plans
  • 2.7 Owkin Inc.
    • 2.7.1 Owkin Inc. Details
    • 2.7.2 Owkin Inc. Major Business
    • 2.7.3 Owkin Inc. AI In Clinical Trials Product and Solutions
    • 2.7.4 Owkin Inc. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Owkin Inc. Recent Developments and Future Plans
  • 2.8 Numerate
    • 2.8.1 Numerate Details
    • 2.8.2 Numerate Major Business
    • 2.8.3 Numerate AI In Clinical Trials Product and Solutions
    • 2.8.4 Numerate AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Numerate Recent Developments and Future Plans
  • 2.9 Neuroute
    • 2.9.1 Neuroute Details
    • 2.9.2 Neuroute Major Business
    • 2.9.3 Neuroute AI In Clinical Trials Product and Solutions
    • 2.9.4 Neuroute AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Neuroute Recent Developments and Future Plans
  • 2.10 AiCure
    • 2.10.1 AiCure Details
    • 2.10.2 AiCure Major Business
    • 2.10.3 AiCure AI In Clinical Trials Product and Solutions
    • 2.10.4 AiCure AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 AiCure Recent Developments and Future Plans
  • 2.11 Ardigen
    • 2.11.1 Ardigen Details
    • 2.11.2 Ardigen Major Business
    • 2.11.3 Ardigen AI In Clinical Trials Product and Solutions
    • 2.11.4 Ardigen AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Ardigen Recent Developments and Future Plans
  • 2.12 Unlearn Al
    • 2.12.1 Unlearn Al Details
    • 2.12.2 Unlearn Al Major Business
    • 2.12.3 Unlearn Al AI In Clinical Trials Product and Solutions
    • 2.12.4 Unlearn Al AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Unlearn Al Recent Developments and Future Plans
  • 2.13 PathAl
    • 2.13.1 PathAl Details
    • 2.13.2 PathAl Major Business
    • 2.13.3 PathAl AI In Clinical Trials Product and Solutions
    • 2.13.4 PathAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 PathAl Recent Developments and Future Plans
  • 2.14 Exscentia
    • 2.14.1 Exscentia Details
    • 2.14.2 Exscentia Major Business
    • 2.14.3 Exscentia AI In Clinical Trials Product and Solutions
    • 2.14.4 Exscentia AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Exscentia Recent Developments and Future Plans
  • 2.15 Aitia Infotech Pvt Ltd.
    • 2.15.1 Aitia Infotech Pvt Ltd. Details
    • 2.15.2 Aitia Infotech Pvt Ltd. Major Business
    • 2.15.3 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product and Solutions
    • 2.15.4 Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Aitia Infotech Pvt Ltd. Recent Developments and Future Plans
  • 2.16 Euretos
    • 2.16.1 Euretos Details
    • 2.16.2 Euretos Major Business
    • 2.16.3 Euretos AI In Clinical Trials Product and Solutions
    • 2.16.4 Euretos AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Euretos Recent Developments and Future Plans
  • 2.17 VeriSIM Life
    • 2.17.1 VeriSIM Life Details
    • 2.17.2 VeriSIM Life Major Business
    • 2.17.3 VeriSIM Life AI In Clinical Trials Product and Solutions
    • 2.17.4 VeriSIM Life AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 VeriSIM Life Recent Developments and Future Plans
  • 2.18 Envisagenics
    • 2.18.1 Envisagenics Details
    • 2.18.2 Envisagenics Major Business
    • 2.18.3 Envisagenics AI In Clinical Trials Product and Solutions
    • 2.18.4 Envisagenics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Envisagenics Recent Developments and Future Plans
  • 2.19 NURITAs
    • 2.19.1 NURITAs Details
    • 2.19.2 NURITAs Major Business
    • 2.19.3 NURITAs AI In Clinical Trials Product and Solutions
    • 2.19.4 NURITAs AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 NURITAs Recent Developments and Future Plans
  • 2.20 BioSymetrics
    • 2.20.1 BioSymetrics Details
    • 2.20.2 BioSymetrics Major Business
    • 2.20.3 BioSymetrics AI In Clinical Trials Product and Solutions
    • 2.20.4 BioSymetrics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 BioSymetrics Recent Developments and Future Plans
  • 2.21 BioAge Labs lInc
    • 2.21.1 BioAge Labs lInc Details
    • 2.21.2 BioAge Labs lInc Major Business
    • 2.21.3 BioAge Labs lInc AI In Clinical Trials Product and Solutions
    • 2.21.4 BioAge Labs lInc AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 BioAge Labs lInc Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI In Clinical Trials Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of AI In Clinical Trials by Company Revenue
    • 3.2.2 Top 3 AI In Clinical Trials Players Market Share in 2022
    • 3.2.3 Top 6 AI In Clinical Trials Players Market Share in 2022
  • 3.3 AI In Clinical Trials Market: Overall Company Footprint Analysis
    • 3.3.1 AI In Clinical Trials Market: Region Footprint
    • 3.3.2 AI In Clinical Trials Market: Company Product Type Footprint
    • 3.3.3 AI In Clinical Trials Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI In Clinical Trials Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global AI In Clinical Trials Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global AI In Clinical Trials Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global AI In Clinical Trials Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America AI In Clinical Trials Consumption Value by Type (2018-2029)
  • 6.2 North America AI In Clinical Trials Consumption Value by Application (2018-2029)
  • 6.3 North America AI In Clinical Trials Market Size by Country
    • 6.3.1 North America AI In Clinical Trials Consumption Value by Country (2018-2029)
    • 6.3.2 United States AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 6.3.3 Canada AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico AI In Clinical Trials Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe AI In Clinical Trials Consumption Value by Type (2018-2029)
  • 7.2 Europe AI In Clinical Trials Consumption Value by Application (2018-2029)
  • 7.3 Europe AI In Clinical Trials Market Size by Country
    • 7.3.1 Europe AI In Clinical Trials Consumption Value by Country (2018-2029)
    • 7.3.2 Germany AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 7.3.3 France AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 7.3.5 Russia AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 7.3.6 Italy AI In Clinical Trials Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI In Clinical Trials Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific AI In Clinical Trials Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific AI In Clinical Trials Market Size by Region
    • 8.3.1 Asia-Pacific AI In Clinical Trials Consumption Value by Region (2018-2029)
    • 8.3.2 China AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 8.3.3 Japan AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 8.3.5 India AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 8.3.7 Australia AI In Clinical Trials Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America AI In Clinical Trials Consumption Value by Type (2018-2029)
  • 9.2 South America AI In Clinical Trials Consumption Value by Application (2018-2029)
  • 9.3 South America AI In Clinical Trials Market Size by Country
    • 9.3.1 South America AI In Clinical Trials Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina AI In Clinical Trials Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI In Clinical Trials Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa AI In Clinical Trials Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa AI In Clinical Trials Market Size by Country
    • 10.3.1 Middle East & Africa AI In Clinical Trials Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia AI In Clinical Trials Market Size and Forecast (2018-2029)
    • 10.3.4 UAE AI In Clinical Trials Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 AI In Clinical Trials Market Drivers
  • 11.2 AI In Clinical Trials Market Restraints
  • 11.3 AI In Clinical Trials Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI In Clinical Trials Industry Chain
  • 12.2 AI In Clinical Trials Upstream Analysis
  • 12.3 AI In Clinical Trials Midstream Analysis
  • 12.4 AI In Clinical Trials Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI In Clinical Trials. Industry analysis & Market Report on AI In Clinical Trials is a syndicated market report, published as Global AI In Clinical Trials Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of AI In Clinical Trials market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,808.36
    		4,212.54
    		5,616.72
    		3,379.08
    		5,068.62
    		6,758.16
    		538,982.40
    		808,473.60
    		1,077,964.80
    		302,968.80
    		454,453.20
    		605,937.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo